Cefluprenam

This classification denotes a cephalosporin antibiotic with the molecular formula C20H25FN8O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 098633Q42P, chemically known as 2-propen-1-aminium, n-(2-amino-2-oxoethyl)-3-(7-(((5-amino-1,2,4-thiadiazol-3-yl)((fluoromethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)-n-ethyl-n-methyl-, inner salt, (6r-(3(e),6-alpha,7-beta(z)))- but generally known as cefluprenam, which bears US NIH Compound Identifier 6536774. European Medicines Agency schedules Cefluprenam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07396MIG. The term CEFLUPRENAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). CEFLUPRENAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefluprenam under HS 29419000 and SITC 54139. As of Q4 2014, CEFLUPRENAM remains the US FDA Preferred Term for this commodity. Cefluprenam bears US NLM identifiers UMLS ID C0652447 and NCI Concept Code C76034. SMILES: S1C2N(C(=O)C2NC(=O)/C(=N\OCF)C2NC(SN2)N)C(=C(C1)/C=C/C[N](CC)(CC(=O)N)C)C(=O)O.